Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chase

Showing results (611-620 of 653) with videos related to

Pageof 66
Sort By:
Science (New York, N.Y.)|July 7, 1995
Regulation of human gene therapyG A Chase, P A DeLeon, K R Dronamraju, et al.
Frontiers in Aging Neuroscience|October 16, 2023
Multifactorial assessment of Parkinson's disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort - extension of the LONG-PD studyBruce A Chase, Rejko Krueger, Lukas Pavelka, et al.
American Journal of Epidemiology|June 1, 1984
The Collaborative Lipid Research Clinics Program Family Study. IV. Familial associations of plasma lipids and lipoproteinsK K Namboodiri, P P Green, E B Kaplan, et al.
Journal of the American Chemical Society|January 8, 2019
Direct Observation of the Orientational Anisotropy of Buried Hydroxyl Groups inside Muscovite MicaAashish Tuladhar, Zizwe A Chase, Marcel D Baer, et al.
Archives of General Psychiatry|June 1, 1995
In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorderG D Pearlson, D F Wong, L E Tune, et al.
Biological Psychiatry|January 1, 1997
Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorderG D Pearlson, P E Barta, R E Powers, et al.
Schizophrenia Bulletin|January 1, 1993
Quantitative D2 dopamine receptor PET and structural MRI changes in late-onset schizophreniaG D Pearlson, L E Tune, D F Wong, et al.
Parkinsonism & Related Disorders|March 25, 2014
Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?Katerina Markopoulou, Joanna M Biernacka, Sebastian M Armasu, et al.
Epidemiology (Cambridge, Mass.)|April 20, 2002
Chronic disease score as a predictor of hospitalizationKathleen G Putnam, Diana S M Buist, Paul Fishman, et al.
The New England Journal of Medicine|October 18, 1990
Lassa fever in the United States. Investigation of a case and new guidelines for managementG P Holmes, J B McCormick, S C Trock, et al.
Pageof 66

Showing results (611-620 of 653) with videos related to

Sort By:
Pageof 66
Science (New York, N.Y.)|July 7, 1995
Regulation of human gene therapyG A Chase, P A DeLeon, K R Dronamraju, et al.
Frontiers in Aging Neuroscience|October 16, 2023
Multifactorial assessment of Parkinson's disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort - extension of the LONG-PD studyBruce A Chase, Rejko Krueger, Lukas Pavelka, et al.
American Journal of Epidemiology|June 1, 1984
The Collaborative Lipid Research Clinics Program Family Study. IV. Familial associations of plasma lipids and lipoproteinsK K Namboodiri, P P Green, E B Kaplan, et al.
Journal of the American Chemical Society|January 8, 2019
Direct Observation of the Orientational Anisotropy of Buried Hydroxyl Groups inside Muscovite MicaAashish Tuladhar, Zizwe A Chase, Marcel D Baer, et al.
Archives of General Psychiatry|June 1, 1995
In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorderG D Pearlson, D F Wong, L E Tune, et al.
Biological Psychiatry|January 1, 1997
Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorderG D Pearlson, P E Barta, R E Powers, et al.
Schizophrenia Bulletin|January 1, 1993
Quantitative D2 dopamine receptor PET and structural MRI changes in late-onset schizophreniaG D Pearlson, L E Tune, D F Wong, et al.
Parkinsonism & Related Disorders|March 25, 2014
Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?Katerina Markopoulou, Joanna M Biernacka, Sebastian M Armasu, et al.
Epidemiology (Cambridge, Mass.)|April 20, 2002
Chronic disease score as a predictor of hospitalizationKathleen G Putnam, Diana S M Buist, Paul Fishman, et al.
The New England Journal of Medicine|October 18, 1990
Lassa fever in the United States. Investigation of a case and new guidelines for managementG P Holmes, J B McCormick, S C Trock, et al.
Pageof 66